-+ 0.00%
-+ 0.00%
-+ 0.00%

*Karyopharm Therapeutics: Top-Line Data From the Phase 3 XPORT-EC-042 Trial in Endometrial Cancer on Track for Mid-2026 >KPTI

Dow Jones·02/12/2026 12:31:00

Please log in to view news